Euro Diagnostica AB recalls is a quantitative/qualitative enzyme-linked immunosorbent assay (ELISA) for the detection of IgG and IgM autoantibodies…
- Recall date
- October 21, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2920-2018
- FDA classification
- Class III
- Brand / firm
- Euro Diagnostica AB
- Sold / distributed
- MN
Why it was recalled
Incorrectly labeled Manufactured by DiaSorin, The correct term should be Distributed by DiaSorin.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
is a quantitative/qualitative enzyme-linked immunosorbent assay (ELISA) for the detection of IgG and IgM autoantibodies specific for the phospholipid cardiolipin in human serum and EDTA, lithium heparin or citrated plasma. It is intended to assess of anti-cardiolipin IgG autoantibody levels in patients where this information is useful in diagnosis, particularly in the assessment of thrombotic risk in patients with systemic lupus erythematosus, or other lupus-like disorders
Get recall alerts
Free email alert whenever Euro Diagnostica AB has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Euro Diagnostica AB